0 items USD 0.00Search
Your search for "Rheumatoid arthritis" gave back 3009 results.
Global Total Ankle Replacement Market is accounted for $158.26 million in 2017 and is expected to reach $327.07 million by 2026 growing at a CAGR of...
颁补迟补濒辞驳:听
Stratistics MRC
April 2019
Price: USD 4,150.00
T Lymphocyte Activation Antigen CD86 (Activation B7-2 Antigen or CTLA 4 Counter Receptor B7.2 or CD86) - Pipeline Review, H1 2018 Summary T...
颁补迟补濒辞驳:听
Global Markets Direct
May 2018
Price: USD 3,500.00
T Lymphocyte Activation Antigen CD80 - Pipeline Review, H2 2019 Summary T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4...
颁补迟补濒辞驳:听
Global Markets Direct
December 2019
Price: USD 3,500.00
The global Rofecoxib market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
颁补迟补濒辞驳:听
GIR
June 2024
Price: USD 3,480.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1...
颁补迟补濒辞驳:听
Global Markets Direct
May 2018
Price: USD 3,500.00
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 4,900.00
The global Certolizumab Pegol market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR...
颁补迟补濒辞驳:听
GIR
December 2024
Price: USD 3,480.00
The global Methotrexate market size was US$ 545 million in 2024 and is forecast to a readjusted size of US$ 655 million by 2031 with a CAGR of 2.7%...
颁补迟补濒辞驳:听
MRRPB5
April 2025
Price: USD 4,250.00
CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors The present Competitive Intelligence Report about CD20 Antibodies - Rituximab...
颁补迟补濒辞驳:听
La Merie Publishing
February 2014
Price: USD 401.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 2,900.00
The global Xeljanz (tofacitnib) Drug market size was valued at USD 1804.8 million in 2023 and is forecast to a readjusted size of USD 1221.3 million...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
The global Rofecoxib market size was valued at US$ million in 2023. With growing demand in downstream market, the Rofecoxib is forecast to a...
颁补迟补濒辞驳:听
LPI
November 2024
Price: USD 3,660.00
The global Orencia (Abatacept) Drug market size was valued at USD 2216.4 million in 2023 and is forecast to a readjusted size of USD 2556 million by...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid...
颁补迟补濒辞驳:听
MRRPB5
March 2024
Price: USD 2,900.00
听
